Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
197.5 GBX | +27.42% | +31.67% | -35.25% |
03/05 | Kelso raises stake in NCC; Transense joins project | AN |
30/04 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.25% | 140M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals Reports 100% Response Rate in Phase 1 Trial of Myeloid Leukemia Combo Drug